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Background: Although the awareness, diagnosis, management of the complications 
associated with diabetes have improved in African countries over the past decade, 
surveillance activities in Tanzania and anecdotal reports from other African countries have 
suggested an increased prevalence of Charcot Neuroarthropathy (CN) over the past few 
years.  
Aim: To characterize the epidemiology and the clinical burden of CN in a large diabetes 
population in Tanzania, and to evaluate outcomes of persons with the condition. 
Methods: This was a prospective analytic cohort study conducted between January 2013 
through December 2015. Following informed consent, patients were followed at the 
outpatient clinic. Detailed clinical assessments and documented presence of diabetic 
peripheral neuropathy (DPN), macrovascular disease and microvascular disease were 
recorded. Education and counselling were part of the follow-up program. 
Results: 3,271 ulcerations were presented at the clinic during the 3-year study period.  571 
(18%) met the case definition for CN; all patients had Type 2 diabetes. The prevalence for 
each of the years 2013, 2014, and 2015 was 19/1192 (1.6%), 209/1044 (20%), and 343/1035 
(34%), respectively; the increases in the slope of the trendline was statistically significant 
(p<0.001).  
Conclusion: The prevalence of CN is increasing in the Tanzanian diabetes patient 
population, and is strongly associated with neuropathy. CN can lead to severe deformity, 
disability, and amputation. Due to the risk of limb amputation, patients with diabetes must 
seek immediate care if signs or symptoms appear and avoid delay in seeking medical 
attention. Early diagnosis of CN by caregivers is extremely important for successful 
outcomes.  
Keywords:   Charcot Neuroarthropathy, Africa, Diabetic foot ulcer, diabetic peripheral 
neuropathy, peripheral arterial diseases, infection, amputation, mortality 
Introduction: 
 
The United Republic of Tanzania is a country in Sub-Saharan Africa (SSA), with a 
population of 60 million people. SSA is experiencing a rapid increase in the prevalence of 
diabetes. In 2019, a report from the international diabetes federation estimated that there were 
19 million people with diabetes in SSA and should the current trend continue, the overall 
prevalence is projected to be 47 million by 2045, which is an increase of 143% 1, 2. 
Diabetic Peripheral Neuropathy (DPN) is one of the most common complications 
affecting patients with diabetes in both developed and less developed countries. The latest 
pooled prevalence rate of DPN across Africa is reported to be 46% with rates ranging 
between 7.5% and 83.4% 3. Previously, Abbas et al found no differences in the rates of DPN 
between African and Asian patients with DFU 4. Also, another old comparative study found 
no significant differences in the presence of DPN in 80% of inpatients with DFU in Tanzania, 
Germany and India 5. Although awareness, diagnosis, management of the complications 
associated with diabetes have improved in African countries over the past decade, 
surveillance activities in Tanzania and anecdotal reports from other African countries have 
suggested an increase in the prevalence of Charcot Neuroarthropathy (CN) over the past few 
years. DPN leads to more severe complications including CN, a limb threatening condtion 
that could become a life-threatening condition in a low resourced setting leading to the 
destruction of bones and joints of the foot 2. A foot deformity, therefore, is often 
accompanied by ulceration, infection and gangrene thus increasing the risk of amputation 2. 
This is of concern because of the potential for CN to set back the positive progress, and 
outcomes, including reducing the rates of leg amputations, achieved through the Step-by-Step 
foot program in Tanzania 6.  
Therefore, it becomes important to characterize the epidemiology and clinical burden 
of CN in a large diabetes population in Tanzania and to evaluate the outcomes of persons 
with this condition. 
 
Methods: 
This was a prospective cohort study. Data was collected of 3,271 ulcerations in 1586 
consecutive patients with Type 2 diabetes who attended the clinic with diabetic foot ulcers 
over a period of three years from January 2013 to December 2015.  Ethical approval to 
conduct this study was sought and granted by the local ethics committee. Core details of all 
people with diabetes attending a single specialist service in Dar es Salaam, for the 
management of diabetic foot ulcers (DFUs) in Tanzania have been reviewed. Patients with 
DFU were prospectively recruited. The centre serves a population of approximately 7 million 
people of mixed ethnicity (African, Indian Asian and Arab). Only the first-ever episode of 
foot ulceration caused in conjunction with CN during the study period was recorded as an 
individual case of CN with an ulcer; multiple ulcers occurring at the same time were counted 
as a single episode of ulcer.  
From this database, patients were selected for inclusion in this study if they met the 
clinical definition of CN and were diagnosed with this condition for the first time by their 
physician. Given the limited resources available in these remote areas, patients were selected 
if they exhibited a high degree of clinical suspicion of CN. The clinical definition of CN, 
includes DPN, joint swelling and dislocation, reported pathological fractures, severe 
deformity (loss of medial longitudinal arch), signs of inflammation, swelling of the foot, 
increased local temperature of the skin and redness 7. 
Following informed consent, patients were followed up at the outpatient’s clinic, with 
data being collected until the end of the study period or the death of the patient. Data 
collected included demographics, such as age, BMI, duration of diabetes, presence of foot 
ulcers, ulcer stage (Wagner grade), reason of ulceration, healed/unhealed ulcers. In addition, 
temperature was measured using infrared thermometry. Due to resource constraints, a foot x-
ray was not done in all patients. 
 
Clinical assessment:  
 
We carried out a detailed clinical assessment and documented the presence of loss of 
protection sense or DPN and peripheral arterial diseases (PAD) using estabished clinical 
protocols. 
 
DPN-: During the clinical examination, patients were assessed for DPN using the 10g 
Semmes-Weinstein monofilament on the plantar aspect of the foot, utilizing the 5-point test 
method, including the 1st, 3rd, 5th metatarsal heads, hallux and heel 8. Any patient who was 
unable to feel the monofilament on one or more sites was classified as neuropathic 8. Tests 
using a biothesiometer and hot and cold test (Sensisometer) were also conducted on every 
patient who attended the clinic during the study period.  
 
PAD-: As per standard clinical protocol pulses palpated included Dorsalis pedalis and 
Posterior tibalis 8. These were graded as normal if both pulses were felt as good bounding 
pulses. If only one pulse was felt or felt with decreased volume, or if no pulse was felt during 
the examination this was noted as some form of arterial impairment to the foot. Doppler tests 
were only done if pulses were not felt. Some patients who could afford CT Scan angiography 
were analysed using this method. 
 
Ulcer classification-: In the presence of ulcers, each ulcer was documented separately, 
detailing the cause of ulceration, classification of ulcerations using the Wagner grading 9, 10 
whether ulcers had undergone sloughectomy and those which resulted in major or minor 
amputations.  
 
Education and counselling-: Education and counselling were part of the follow-up program. 
Every high risk patient (DPN, PAD and history of past ulcer or amputation) was given 
education either on a one to one basis or in a group 6. The education was weekly and 
importance was given to footwear and offloading. Education included the following 
recommendations: Look at feet every day, learn to look for deformity and complications, 
learn to take care of the diabetic skin, learn to take care of nails, what to look for in socks, 
what to look in footwear, and identify problems and act fast 6. Become familiar with changes 




Out of 3,271 ulcerations presenting at the clinic, 571 (18%) ulcerations in 226 
(14.24%) Type 2 diabetes patients with a positive diagnosis of Charcot neuroarthropathy, 
were identified during the 3year study period. 2700 ulcers were attributed to 1360 non-
charcot patients. Out of the 1586 patients reported within the study, in 2013, there were 17 
CN patients and 517 patients without CN. This increased to 86 and 374 patients in 2014 and 
123 and 469 in 2015.  
Patient demographics: median age 56 years (range between 14 to 92 years), the 
median duration of diabetes was 10 years (range 1-33 years); median BMI 26.6 kg/m2 (range 
18-49 kg/m2). With regards to microvascular disease, none had retinopathy or nephropathy. 
Delay in seeking medical treatment was common (median 7 days (range 1-360 days). Five 
patients were on diet only, 144 were on oral hypoglycaemic agents, 76 were on insulin and 1 
patient was on both oral medication and insulin.  
All presenting cases had active ulcerations, all of whom had a history of previous 
ulcers, with some of them presenting with multiple ulcerations. This amounted to 571 new 
ulcerations over the 3 years. During this period, 19 ulcers were diagnosed in 2013, 209 
ulcerations in 2014 and 343 ulcerations in 2015 (Table 1, Figure 1), indicating a statistically 
significant increase in the slope of the trend line (p=0.001). 
<table 1 here> 
 
<figure 1 here> 
 
Figure 1: Prevalence of CN ulcers during the study period 
 
One hundred and forty-seven ulcerations were neuro-ischaemic and 424 were purely 
neuropathic in nature. At presentation, 397 ulcers (70%) were classified as Wagner grade 2, 
72 (12%) as Wagner grade 3 and 102 (18%) were Wagner grade 4. Table 2 reports ulcer 
demographics, including those that healed and those that did not heal until the end of the 
study period. Over 90% of these ulcers were presented in the midfoot region. Common 
causes of ulceration included blisters (36%), callus (13%), prick with a sharp object (9.3%), 
rat bites (9%), blunt trauma (7%) and burns (4%). The majority of ulceration underwent 
sloughectomy (90%) as part of the medical treatment. Delay in seeking medical treatment 
was common amongst this cohort, with a median of 7 days, ranging between 1 to 360 days 
before initial assessment. 
 
<table 2 here> 
 
In this cohort of 571 ulcers, 395 (69.2%) healed during the study period, taking a 
mean of 141 days (SD 62days). The mean age of patients with healed ulcers was 55.7% (SD 
12.01) with a mean fasting blood glucose of 13.61 (SD 8.4) mmol/L and 11.1 (SD7.2) years 
mean duration of diabetes.  One hundred seventy-six (30.8%) ulcers remained unhealed by 
the end of the study period.  The mean age of these patients was 53.4 (SD13.83) years, who 
had a mean fasting blood glucose of 13.89 (SD8.24) mmol/L, which is quite comparable to 
those of the healed cohort. Duration of diabetes was 10.66 (SD8.05) years, which is also 
comparable to that of the healed cohort.  Out of these unhealed ulcers, 54 patients (23.9%) 
from the 226 patients who presented at the clinic with CN sustained some form of 
amputation. There were no amputations in 2013, 36 (66.7%) in 2014 and 18 (33.3%) in 2015.  
 
Discussion: 
The results from this study demonstrate the increasing prevalence of CN ulcerations 
in Tanzania. Although in 2015 fewer cases of diabetic non – CN ulcerations were seen at the 
diabetic clinic, there was a significant increase in the number of CN presenting with 
ulcerations at the first visit. We observed an exponential increase (from 3.2 to 21 percent) of 
CN patients between the first and the second year within the study period. Although this is 
not attributed to any specific reason, the trend in increased CN was consistent over the 3 
years of the study period. The median duration of diabetes amongst this population was of 10 
years, confirming that it is commonest in those patients with long-term diabetes. Whilst it 
might be impossible to totally prevent diabetic foot ulceration, it is certainly feasible to 
prevent the progression of small ulceration progressing into more complicated wounds, and 
possibly CN in the presence of peripheral neuropathy. This study has shown that the 
prevalence of CN increased over the 3 years and those patients who presented with lower 
ulcer classification managed to heal, whilst those that presented with higher ulcer grading had 
more difficulty in healing. Due to this fact diabetes patients in Tanzania should be alerted on 
the importance of seeking medical help during the early stages of foot-related ulcerations and, 
healthcare professionals should instigate a proper investigation as to the aetiology of the 
increasing incidence of CN in Africa. 
 
Recognizing this condition at an early stage encourages timely initiation of 
appropriate therapy, thus reducing the burden of this chronic condition both on the patient 
and health care systems. However, various challenges prevent this early detection in Tanzania 
especially amongst the poorer populations who cannot seek private medical attention. 
Foremost amongst these challenges are the huge, sometimes insurmountable, distances that 
patients would have to travel – mostly on already-afflicted feet – in order to cover the great 
distances from rural areas, where medical treatment may not be available. Poverty, 
unhygienic conditions, the purchase of appropriate footwear and the common practice of 
walking barefoot in rural communities 2, 11, are also often inevitable challenges that these 
patients face daily.  
 
In this study, the median age was of 56 years, which is in concordance with other 
reported literature which highlight that CA presents in the 5th and 6th decade of life 12,13. This 
is also similar to another study performed in a neighbouring SSA country 12. Although in this 
study CN was reported to be equally distributed between midfoot and forefoot 12, in our 
population 90% of all ulcers presented in the midfoot. The ulcers that healed presented on a 
lower Wagner grading when compared to those that did not heal. Indeed, there were 74.2% 
Grade 2 vs 59.1% between the healed and non-healed groups respectively, and 15.2% vs 23.9 
Wagner Grade 4, respectively. These statistics indicate that the lower the Wagner grading of 
the ulcer, the more probability of healing, advocating for the need for early intervention at the 
initial stages of the ulcer. However, as discussed earlier, there may be significant challenges 
that contribute to delay in seeking medical attention.  
 
To augment these barriers to timely diagnosis and treatment, acute CN may often be 
misdiagnosed for cellulitis, sprain, gout or deep venous thrombosis (DVT) due to lack of 
available facilities in centres in Tanzania. This emphasises the importance of additional 
training for health care professionals to help them to recognize the early signs and symptoms 
of this condition. Health care professionals, where there is only basic diagnostic equipment 12, 
should be encouraged to routinely screen feet of diabetic patients and to refer promptly to 
more specialist diabetic services upon suspicion of CN.  Also, within this paper, we report 
that none of the patients had retinopathy or nephropathy. One could perceive this observation 
as unusual. However, it needs to be highlighted that these tests were not completed as a part 
of this study and they were independently carried out as a part of the wider healthcare system 
in Tanzania. The system requires the patients to complete these tests in different places. 
Nephropathy was tested by the levels of Serum Creatinine and Serum urea within a 
recognised hospital facility. The Eye department within the public hospital checked and 
reported for retinopathy using an ophthalmoscope. Whilst for this paper, we report the results 
as presented to us, future studies should make a provision for structured and thorough 
investigations into these topics. In addition, lack of disease confirmation using foot x-rays in 
many paitents within study could be seen as a limitation.  
 
The study was based on primary data gathered prospectively, hence allowing the 
timely collection of the parameters of interest. This study was conducted in one centre; the 
scenario in more rural areas where no such centres exist was not investigated and could draw 
a more morbid picture with regards to the prevalence of CN since in African countries, 
medical insurance or reimbursement of medical expenses are not always available. Amongst 
the poorer populations, such medical care could cost more than 2 years of their average 
income 14, hence making it very difficult for patients to seek immediate help. Access to more 
advanced imaging modalities was limited, both logistically and financially, however several 
cases presented to the clinic in the acute phase where it is well known that radiological 
changes in this condition may be relatively difficult to appraise.  
 
Conclusion: 
CN amongst diabetes patients in Tanzanian is increasing in prevalence and develops 
as a result of neuropathy.  CN can lead to severe deformity, disability, and amputation. Due 
to its seriousness, it is important that patients with diabetes seek immediate care if signs or 
symptoms appear and avoid delay in seeking medical attention. Early diagnosis of CN by 
caregivers is extremely important for successful outcomes. Warmth to the touch, redness and 
localized swelling with tenderness in the feet are key clinical findings that might herald a CN.  
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